[{"AccountsPayableCurrent_0_Q1_USD":3409000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-217000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":30000.0,"DeferredRentCreditNoncurrent_0_Q1_USD":2218000.0,"IncreaseDecreaseInDeferredRevenue_1_Q1_USD":5065000.0,"IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_1_Q1_USD":-0.56,"DeferredRevenueCurrent_0_Q1_USD":5765000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-13152000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":307009000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":196000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q1_USD":2088000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":69842000.0,"OtherAssetsNoncurrent_0_Q1_USD":389000.0,"NonoperatingIncomeExpense_1_Q1_USD":135000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q1_USD":15200000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q1_shares":3427003.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":204000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":351000.0,"OtherLiabilitiesCurrent_0_Q1_USD":436000.0,"ProceedsFromIssuanceOfConvertiblePreferredStock_1_Q1_USD":0.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":935000.0,"ReceivablesNetCurrent_0_Q1_USD":5010000.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":46883000.0,"InvestmentIncomeAmortizationOfDiscount_1_Q1_USD":4000.0,"IncreaseDecreaseInDeferredCharges_1_Q1_USD":7000.0,"DividendsCommonStock_1_Q1_USD":0.0,"DeferredRevenueNoncurrent_0_Q1_USD":3300000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":14146000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":91529000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":136649000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":136866000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":217000.0,"WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_1_Q1_shares":51098.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q1_USD":-204000.0,"MarketableSecuritiesCurrent_0_Q1_USD":46670000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":1558000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":9864000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":2421000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":6258000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":69872000.0,"LiabilitiesCurrent_0_Q1_USD":13442000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":150889000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":5010000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":237000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-12902000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":3289000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.56,"CommonStockValue_0_Q1_USD":2000.0,"CommonStockSharesOutstanding_0_Q1_shares":24334007.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":91529000.0,"AssetsCurrent_0_Q1_USD":146894000.0,"Assets_0_Q1_USD":150889000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":1611955.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":7000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-46981000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-8745000.0,"NetIncomeLoss_1_Q1_USD":-13139000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":98000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":30000.0,"ShareBasedCompensation_1_Q1_USD":2088000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":10683000.0,"PreferredStockValue_0_Q1_USD":null,"OperatingIncomeLoss_1_Q1_USD":-13037000.0,"OperatingExpenses_1_Q1_USD":13972000.0,"DepreciationAndAmortization_1_Q1_USD":199000.0,"WeightedAverageNumberOfSharesIssuedBasic_1_Q1_shares":23317161.0,"CommitmentsAndContingencies_0_Q1_USD":null,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":23266063.0,"StockholdersEquity_0_Q1_USD":131929000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-175089000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":3606000.0,"ProfitLoss_1_Q1_USD":-13139000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":69842000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":3685000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":3832000.0,"WorkersCompensationLiabilityCurrent_0_Q1_USD":1497000.0,"Ticker":"RAPT","CIK":"1673772","name":"RAPT THERAPEUTICS, INC.","OfficialName":"RAPT Therapeutics Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"595076458.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200514"}]